Huiping Zhang, PhD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Psychiatry

PhD, Queen's University
MS, Tongji Medical University



Huiping Zhang, PhD, is an Associate Professor of Psychiatry at the Boston University School of Medicine. He has a long history with the Yale University School of Medicine, where he completed his postdoc training and then served as a Research Associate Scientist (equivalent to Research Assistant Professor), Assistant Professor (tenure-track), and Research Scientist (equivalent to Research Associate Professor) before coming to Boston University. He is an editorial board member of academic journals such as the Journal of Addiction Research & Therapy, the Journal of Depression & Anxiety, and PLOS One. His research focused on genetic and epigenetic studies of substance use disorders (SUDs) and related psychiatric disorders and traits. He is currently the PI of two research grants (R01 and R21) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and one research grant from the Boston University Clinical Translational Science Institute (CTSI). Additionally, he is the subcontract PI of a R01 from the National Institute of Child Health and Human Development (NICHD).

Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Biomedical Genetics

Member
Boston University
Genome Science Institute


Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder
03/01/2022 - 12/31/2026 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
1R01AA029758-01

Brain microRNA-mRNA regulatory networks and alcohol use disorders
08/01/2017 - 07/31/2022 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5R01AA025080-05

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder
10/01/2018 - 05/31/2022 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD
5R01HD096798-04

Salivary MicroRNAs as Biomarkers for Alcohol Dependence
08/01/2017 - 04/30/2019 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
7R21AA023068-03



Title


Yr Title Project-Sub Proj Pubs
2022 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 1R01AA029758-01
2020 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-05 13
2019 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-04 13
2018 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-03 13
2017 Brain microRNA-mRNA regulatory networks and alcohol use disorders 7R01AA025080-02 13
2016 Brain microRNA-mRNA regulatory networks and alcohol use disorders 1R01AA025080-01 13
2016 Salivary MicroRNAs as Biomarkers for Alcohol Dependence 5R21AA023068-02 8
2016 Salivary MicroRNAs as Biomarkers for Alcohol Dependence 7R21AA023068-03 8
2015 Salivary MicroRNAs as Biomarkers for Alcohol Dependence 1R21AA023068-01A1 8
2011 Association and Function of Opioid Receptor Gene Variants to Substance Dependence 5R00DA022891-05 18
Showing 10 of 15 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Liu Y, Zhang H. RNA m6A Modification Changes in Postmortem Nucleus Accumbens of Subjects with Alcohol Use Disorder: A Pilot Study. Genes (Basel). 2022 May 27; 13(6). PMID: 35741720; PMCID: PMC9222907; DOI: 10.3390/genes13060958;
     
  2. Borrelli KN, Wachman EM, Beierle JA, Taglauer ES, Jain M, Bryant CD, Zhang H. Effect of Prenatal Opioid Exposure on the Human Placental Methylome. Biomedicines. 2022 May 17; 10(5).View Related Profiles. PMID: 35625888; PMCID: PMC9138340; DOI: 10.3390/biomedicines10051150;
     
  3. Lim Y, Beane-Ebel JE, Tanaka Y, Ning B, Husted CR, Henderson DC, Xiang Y, Park IH, Farrer LA, Zhang H. Exploration of alcohol use disorder-associated brain miRNA-mRNA regulatory networks. Transl Psychiatry. 2021 10 02; 11(1):504.View Related Profiles. PMID: 34601489; PMCID: PMC8487426; DOI: 10.1038/s41398-021-01635-w;
     
  4. Moazzam M, Yim T, Kumaresan V, Henderson DC, Farrer LA, Zhang H. Analysis of telomere length variation and Shelterin complex subunit gene expression changes in ethanol-exposed human embryonic stem cells. J Psychiatr Res. 2021 11; 143:543-549.View Related Profiles. PMID: 33243459; PMCID: PMC8126580; DOI: 10.1016/j.jpsychires.2020.11.027;
     
  5. Wachman EM, Wang A, Isley BC, Boateng J, Beierle JA, Hansbury A, Shrestha H, Bryant C, Zhang H. Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study. Explor Med. 2020 Jun; 1(3):124-135.View Related Profiles. PMID: 33763662; PMCID: PMC7985727; DOI: 10.37349/emed.2020.00009;
     
  6. Lin H, Wang F, Rosato AJ, Farrer LA, Henderson DC, Zhang H. Prefrontal cortex eQTLs/mQTLs enriched in genetic variants associated with alcohol use disorder and other diseases. Epigenomics. 2020 05; 12(9):789-800.View Related Profiles. PMID: 32496132; PMCID: PMC7607393; DOI: 10.2217/epi-2019-0270;
     
  7. Dai Y, Hu R, Pei G, Zhang H, Zhao Z, Jia P. Diverse types of genomic evidence converge on alcohol use disorder risk genes. J Med Genet. 2020 11; 57(11):733-743. PMID: 32170004; PMCID: PMC7487038; DOI: 10.1136/jmedgenet-2019-106490;
     
  8. Lin Y, Kranzler HR, Farrer LA, Xu H, Henderson DC, Zhang H. An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence. Pharmacogenomics J. 2020 10; 20(5):672-680.View Related Profiles. PMID: 32029903; PMCID: PMC7415483; DOI: 10.1038/s41397-020-0158-1;
     
  9. Fu Y, Zhou N, Yu Y, Zhang H, Sun Y, Zhang M, Chen X, Wang Y, Yu Q. Profiling of schizophrenia-associated serum peptides by MALDI-TOF-MS. J Neural Transm (Vienna). 2020 01; 127(1):95-101. PMID: 31786691; DOI: 10.1007/s00702-019-02108-7;
     
  10. Yang M, Zhou N, Zhang H, Kang G, Cao B, Kang Q, Li R, Zhu X, Rao W, Yu Q. Kininogen-1 as a protein biomarker for schizophrenia through mass spectrometry and genetic association analyses. PeerJ. 2019; 7:e7327. PMID: 31346501; PMCID: PMC6642793; DOI: 10.7717/peerj.7327;
     
Showing 10 of 74 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 74 publications over 20 distinct years, with a maximum of 9 publications in 2015

YearPublications
19961
20021
20041
20062
20074
20082
20093
20104
20112
20128
20135
20144
20159
20167
20177
20182
20194
20205
20211
20222

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Substance Use Disorders
Psychiatric Genetics
Epigenetics
Contact for Mentoring:

72 East Concord Street
Boston MA 02118
Google Map


Zhang's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department